Korobelnik, Jean-François
Daien, Vincent
Faure, Céline
Tadayoni, Ramin
Giocanti-Auregan, Audrey
Dot, Corinne
Kodjikian, Laurent
Massin, Pascale
Funding for this research was provided by:
Bayer Consumer Care, AG, Pharmaceuticals (n/a)
Article History
Received: 5 November 2019
Revised: 20 December 2019
Accepted: 24 December 2019
First Online: 2 January 2020
Compliance with ethical standards
:
: JFK has been a consultant for Allergan, Bayer, Beaver-Visitec, Horus Pharma, Krystal Biotech, Chengdu Kanghong, Nano Retina, Novartis, Novo Nordisk, Oxurion, Roche, Théa, and Zeiss; VD has received consulting fees from Bayer, Novartis, Théa, and Horus Pharma; CF and CD have received consulting fees from Allergan, Bayer, and Novartis; RT has received consulting fees from Alcon, Bausch & Lomb, FCI Ophthalmics, Moria, Optovue, Zeiss, Alimera, Allergan, Bayer, Genentech, Novartis, Roche, and Théa; AGA has received consulting fees from Allergan, Bayer, Novartis, and Optos; LK has been a consultant for AbbVie, Alcon, Allergan, Bayer, Krystal Biotech, Novartis, Regeneron, and Théa; and PM has received consulting fees from Bayer, Novartis, Allergan, Horus Pharma, Sanofi, and Merck Sharp & Dohme.
: All procedures performed involving human participants were in accordance with the ethical standards of the (place name of institution and/or national research committee) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.